Associated Papers
Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, MEN1 Gene-Related Tumors, and Insulin Resistance.
Carsote M et al.
International Journal of Molecular Sciences, 2024
Whole-exome sequencing as a tool for searching for genetic background modifiers in MEN1 patients with neuroendocrine pancreatic tumours, including insulinomas.
Skalniak A et al.
Endokrynologia Polska, 2023
Cockayne syndrome, MEN1, and genomic variants: Exome sequencing is changing our view of the genetic landscape.
Oska SR et al.
Pediatric Dermatology, 2021
Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A et al.
Nature Reviews. Endocrinology, 2021
Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family.
Gilis-Januszewska A et al.
Genes, 2021
Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1.
Dantas NCB et al.
Frontiers in Endocrinology, 2019
Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome.
Subasinghe CJ et al.
Case Reports in Endocrinology, 2018
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
Chou WC et al.
International Journal of Biological Sciences, 2016
27994516 (PubMed )
Supplement: ijbsv12p1523s1.xls › mutation_table
Genetic and epigenetic analysis in korean patients with multiple endocrine neoplasia type 1.
Chung YJ et al.
Endocrinology and Metabolism (seoul, Korea), 2014
Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients.
Cebrián A et al.
Journal of Medical Genetics, 2003
Multiple endocrine neoplasia type 1.
Pannett AA et al.
Endocrine-related Cancer, 1999
Select a paper to view details